5 must-read analyst questions from Globe Life’s Q3 earnings call

Globe Life’s third quarter saw solid revenue growth, yet the market responded negatively after adjusted earnings came in below analyst expectations. Management pointed to operational headwinds in its United American General Agency Division, most notably due to a process change at the Centers for Medicare & Medicaid Services (CMS) that led to elevated claims. Additionally, the Evri group health business experienced higher-than-expected severity in claims, contributing to lower underwriting margin